LONDON--(BUSINESS WIRE)--May 21, 2026--
AV Laboratories, a science-led skincare company founded by pioneers in IVF solutions, regenerative medicine, and stem cell therapy, today announced it will exhibit at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE 2026, taking place in London from 5 - 8 July 2026. The company will welcome clinicians, embryologists, fertility specialists, researchers, partners, and industry participants at Booth A22.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521731974/en/
“ESHRE is deeply personal for us because this is the community that shaped our scientific foundation,” said Ami Mezezi, CEO and Co-Founder of AV Laboratories. “Our work in IVF taught us how profoundly cellular health, precision, and care matter. With AV Laboratories, we are bringing that same philosophy into skincare, helping women feel supported through some of the most important and sensitive stages of their lives.”
At ESHRE 2026, AV Laboratories will present its award-winning skincare portfolio and a new vision for women’s skincare, one that connects reproductive science, cellular health, and skin longevity through a more holistic understanding of how skin’s needs change over a lifetime. By returning to the IVF community, AV Laboratories aims to open a new conversation around how fertility and women’s health providers can support not only clinical outcomes, but also the everyday confidence and wellbeing of the women they serve.
“We can’t keep separating these experiences into different categories anymore. Women’s health and skincare should be viewed as part of one connected journey,” Jessica Martin, Director of Corporate Communication at AV Laboratories. “As a mom of two, I remember how important it was to feel confident in the products I used, especially while breastfeeding. During that stage of life, you think carefully about everything, what you eat, what you use, what touches your skin. We want to make at least one part of that journey feel simpler by creating skincare women can genuinely trust.”
AV Laboratories’ portfolio is powered by AVL SOM3®, the brand’s patented molecular skincare technology designed to deliver precision nourishment to skin and support the key building blocks associated with younger-looking skin: collagen, elastin, and NAD+. “At AV Laboratories, we don’t formulate in isolation,” said Sylwia Pawlaczyk, COO and Master Formulator at AV Laboratories. “I spend a lot of time thinking about how we build the company around real clinical needs, not assumptions.” Dual-purpose formulations are designed for simple, effective routines, combining AVL SOM3® with clinical-grade actives that work with the skin to support hydration, barrier resilience, visible firmness, elasticity, radiance, and the appearance of smoother, healthier-looking skin.
"As both a dermatologist and a mother who had my two children through IVF, I understand firsthand how intentional women become about every choice during this journey,” said Dr. Dendy Engelman, board-certified dermatologist and Scientific Advisory Board Member at AV Laboratories. “Patients are making deeply personal decisions about what they put in and on their bodies, and they deserve skincare that feels clear, considered, and grounded in real science. What excites me about AV Laboratories is that it brings together breakthrough science, elegant formulation, and a true understanding of women’s needs, from IVF and motherhood to long-term skin longevity.”
At Booth A22, AV Laboratories will offer an educational experience designed around the brand’s journey from IVF science to molecular skincare, including:
AV Laboratories Fertility Clinic Skincare Program
For fertility practices, AV Laboratories’ clinical program is designed to be simple to introduce and easy to communicate to patients. The program gives clinics a way to offer science-backed skincare education, trusted product recommendations, and supportive wellness resources for women who may be more conscious of what they use during fertility treatment, pregnancy, breastfeeding, and beyond.
“Through my work with fertility clinics, I see how much trust patients place in their care teams, ” said Nathalie Boonen, IVF and Medical Clinic Partnerships Expert.
“Women going through fertility treatment want guidance they can deeply rely on, in every aspect of their care, including what they can use on their skin. A thoughtful, science-backed skincare program gives clinics a simple way to meet that need and elevate the patients' experience”
AV Laboratories invites ESHRE 2026 participants to visit Booth A22 to experience the brand’s skincare portfolio, learn more about AVL SOM3®, and explore partnership opportunities for fertility, women’s health, and clinical wellness.
To schedule a meeting with AV Laboratories during ESHRE 2026, participants are encouraged to contact the team in advance or visit Booth A22 during exhibition hours.
From pioneering IVF solutions to reimagining the appearance of skin aging
Before founding AV Laboratories, Ami and Monica Mezezi helped shape the IVF industry through their work at LifeGlobal. Founded by Monica, LifeGlobal pioneered single-step culture media for IVF, a breakthrough that contributed to changing the standard of care for fertility clinics around the world. LifeGlobal was acquired by CooperSurgical in 2018. Ami also co-founded EvolveGene, a genetic testing company focused on using molecular insights to support more informed, personalized health decisions, also acquired by CooperSurgical. In 2021, they founded CaseBioscience, a company developing technologies for regenerative medicine and stem cell therapy. At AV Laboratories, Ami and Monica draw on their deep experience in reproductive health, regenerative medicine, quality-controlled manufacturing, and cellular science to reimagine how we think about the appearance of skin aging.
About AV Laboratories
AV Laboratories is a science-led skincare company founded by pioneers in IVF solutions, biotechnology, molecular biology, stem cell research, and cellular science. The company develops advanced skincare solutions rooted in its patented AVL SOM3® technology, a molecular skincare complex inspired by decades of work in cellular nourishment, precision formulation, and women’s health. AV Laboratories is dedicated to helping skin look and feel healthier for longer through science-backed, clinically validated, and responsibly formulated skincare.
AV Laboratories, Founded by Pioneers of IVF Solutions, to Launch Fertility Clinic Program Featuring Its Award-Winning Skincare at ESHRE 2026 in London
BUNIA, Congo (AP) — People set fire to an Ebola treatment center in a town at the heart of the outbreak in eastern Congo on Thursday after being stopped from retrieving the body of a local man, a witness and a senior police officer said, as fear and anger grow over a health crisis that doctors are struggling to contain.
The arson attack in Rwampara reflects the challenges of health workers trying to curb a rare Ebola virus by using stringent measures that might clash with local customs, such as burial rites. The disease has been spreading for weeks in a region lacking in health facilities and where armed conflict has displaced many people.
The dangerous work of burying suspected victims is being managed wherever possible by authorities because the bodies of those who die from Ebola can be highly contagious and lead to further spread when people prepare bodies for burial and gather for funerals.
That policy can be extremely unpopular with victims' families and friends, who aren't given the chance to bury their loved ones.
The center in Rwampara was burned by local youths who became angry while trying to retrieve the body of a friend who had apparently died of Ebola, according to a witness who spoke to The Associated Press by telephone.
“The police intervened to try to calm the situation, but unfortunately they were unsuccessful,” said Alexis Burata, a local student who said he was in the area. "The young people ended up setting fire to the center. That’s the situation.”
An AP journalist saw people break into the center and set fire to objects inside and also to what appeared to be the body of at least one suspected Ebola victim that was being stored there. Aid workers fled the treatment center in vehicles.
Deputy Senior Commissioner Jean Claude Mukendi, head of the public security department, Ituri Province, said it was due to youths who didn't understand the protocols required for burying suspected Ebola victims.
“His family, friends, and other young people wanted to take his body home for a funeral even though the instructions from the authorities during this Ebola virus outbreak are clear," Mukendi said. "All bodies must be buried according to the regulations."
Hama Amadou, the field Coordinator for the humanitarian organization ALIMA, which had teams working at the center, said later that calm had been restored and the aid teams were continuing their work at the center.
The flash of anger underlined the complications faced by both Congolese authorities and an array of aid agencies trying to stem an outbreak the World Health Organization has declared a public health emergency of international concern.
There are 148 suspected deaths and nearly 600 suspected cases, according to the U.N., with two cases including one death in neighboring Uganda. But the head of the WHO has said the outbreak is almost certainly much larger and has also expressed concern over the speed of the spread.
The risk of the outbreak spreading globally is low, the WHO has said, but high regionally with the Ituri Province at the center of the outbreak bordering Uganda and South Sudan.
“The priority now is to act quickly and work closely with communities, as the coming days are critical,” said Ariel Kestens, the head of the International Federation of Red Cross and Red Crescent Societies delegation in Congo.
Health workers and aid groups have said they are in dire need of more supplies and staff to respond. Also, there is no available vaccine or medicine for the Bundibugyo strain responsible for the outbreak.
An expert said this week it would be at least six to nine months before one would be available.
The virus spread undetected for weeks following the first known death in late April as Congolese health authorities tested for a different Ebola virus more commonly responsible for outbreaks in the country.
On Thursday, the M23 rebel group that controls parts of eastern Congo reported a confirmed case near the major city of Bukavu, some 500 kilometers (310 miles) south of the outbreak’s epicenter in Ituri Pronvince. The person died, M23 said in a statement.
As well as Ituri, other cases had been confirmed in North Kivu province and two in Uganda. But the announcement by M23 was the first confirmation of a case in South Kivu.
Health officials have not yet found “patient zero,” according to the WHO.
Investigations are continuing into the source of the outbreak, but “given the scale, we are thinking that it has started probably a couple of months ago,” said Anaïs Legand, a viral hemorrhagic fevers expert at the WHO.
India and the African Union said Thursday that the India-Africa Forum Summit, scheduled to be held next week in New Delhi, had been postponed due to the “evolving health situation in parts of Africa.”
On Wednesday, Congo’s soccer team canceled a three-day World Cup preparation training camp and a planned farewell to fans in the capital Kinshasa because of the Ebola outbreak.
The U.S. Department of Homeland Security announced that any flights carrying American citizens or U.S. permanent residents who had visited Congo, Uganda or South Sudan in the previous 21 days would be redirected to Washington Dulles International Airport from Thursday, where there would be enhanced Ebola screening.
The U.S. had already put in place restrictions banning other travelers who had been in those three countries in the previous 21 days from entering the U.S.
Pronczuk reported from Dakar, Senegal and Imray from Cape Town, South Africa. Associated Press writers Jamey Keaten in Geneva; Jean Yves Kamale in Kinshasa, Congo; and Wilson McMakin in Dakar, Senegal contributed to this report.
For more on Africa and development: https://apnews.com/hub/africa-pulse
The Associated Press receives financial support for global health and development coverage in Africa from the Gates Foundation. The AP is solely responsible for all content. Find AP’s standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org.
A health worker prepares an Ebola treatment center at the General Hospital in Bunia, Congo, Thursday, May 21, 2026. (AP Photo/Moses Sawasawa)
EDS NOTE: GRAPHIC CONTENT - The remains of a body lie on the ground at an Ebola treatment center after it burned down in Rwampara, Ituri province, Congo, Thursday, May 21, 2026. (AP Photo/Dirole Lotsima Dieudonne)
A woman mourns her child, who died of Ebola, at the General Hospital in Bunia, Congo, Thursday, May 21, 2026. (AP Photo/Moses Sawasawa)
A U.S. doctor, who was in contact with people infected with Ebola in Uganda, arrives in a hospital in Prague, Czech Republic, Thursday, May 21, 2026. (AP Photo/Petr David Josek)
A convoy of emergency vehicles in Schönefeld, Germany, transports the family of a U.S. national who tested positive for Ebola in Congo, from the airport to where the patient is being examined in a special isolation ward of the Charite hospital in Berlin, on Wednesday, May 20, 2026. (Michael Ukas/dpa via AP)
Red Cross workers carry the body of a person who died of Ebola into a coffin at a health center in Rwampara, Congo, Wednesday, May 20, 2026. (AP Photo/Moses Sawasawa)
A woman cries as Red Cross workers carry the coffin of a person who died of Ebola from a health center in Rwampara, Congo, Wednesday, May 20, 2026. (AP Photo/Moses Sawasawa)
